On analyzing the mRNA expression levels of LPAR2 in pan-cancer and normal tissues using Oncomine, we found that LPAR2 expression was higher in bladder, brain and central nervous system (CNS), breast, colorectal, kidney, and lung cancers and lymphoma than in normal control tissues (Fig. 2A). Here, LPAR2 is linked to cancer.